ABSTRACT
The
green fluorescent protein (GFP) gene offers many advantages as a
viability reporter for high-throughput antimicrobial drug screening.
However, screening for antituberculosis compounds by using GFP driven
by the heat shock promoter, hsp60, has been of limited utility
due to the low signal-to-noise ratio. Therefore, an alternative
promoter was evaluated for its enhanced fluorescence during
microplate-based culture and its response to 18 established
antimicrobial agents by using a green fluorescent protein microplate
assay (GFPMA). Mycobacterium tuberculosis
strains H37Rv, H37Ra, and Erdman were transformed with pFPCA1, which
contains a red-shifted gfp gene driven by the acetamidase
promoter of M. smegmatis mc2155. The pFPCA1
transformants achieved higher levels of GFP-mediated fluorescence than
those carrying the hsp60 construct, with signal-to-noise
ratios of 20.6 to 27.8 and 3.8 to 4.5, respectively. The MICs of 18
established antimicrobial agents for all strains carrying pFPCA1 in the
GFPMA were within 1 to 2 twofold dilutions of those determined by
either the fluorometric or the visual microplate Alamar Blue assay
(MABA). No significant differences in MICs were observed between
wild-type and pFPCA1 transformants by MABA. The optimized GFPMA is
sufficiently simple, robust, and inexpensive (no reagent costs) to be
used for routine high-throughput screening for antituberculosis
compounds.